The discovery of this regulatory axis indicates that ADAMTS1 is a key downstream effector molecule in the “classic pathological pathway driving heart failure,” further highlighting its central role in post-myocardial infarction heart failure. This evidence concerns the gene ADAMTS1 and myocardial infarction.